Welcome to neditol.co.uk
Neditol? XL is a prolonged-release capsule of tolterodine tartrate indicated in symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.1
- 4mg?prolonged-release capsules
- 2mg prolonged-release capsules (available for the first time in the UK)
Neditol XL is bioequivalent?to Detrusitol? XL (Pfizer Limited, Surrey, UK).2
Neditol XL offers significant savings to your practice and?clinical commissioning group (CCG).
Typically generic products are listed in category M of the UK Drug Tariff. On patent expiry of the originator product, the market price then declines significantly and savings?are eventually passed on to the practice or CCG.
However, category C Drug Tariff products are often more difficult to manufacture and their reimbursed price remains the same whether it be an originator product or generic. Tolterodine 4mg prolonged-release capsules are in category C of the Drug Tariff.3
Neditol XL is different as Aspire Pharma have priced the product with the Department of Health to give your practice or CCG savings of up to 50%?on the cost of the Category C Drug Tariff price for?tolterodine 4mg prolonged-release capsules when Neditol XL is prescribed by brand.3*
At CCG level, the average cost of tolterodine XL prescribing is >￡160,000. A change to Neditol XL would result in prescribing savings >￡80,100.4**
In addition to making 50% cost savings,* Neditol XL:
? Available from mainline wholesalers;
? High level of stockholdings;
? Price guaranteed till 2019;***
? Bioequivalent to the originator brand;2
? Additional 2mg strength.